Search - tctmd.com

Displaying 721 - 740 of 824

Sort: Relevancy | Date

Presentation

Outcomes Up to 7 Years After Transcatheter Pulmonary Valve Replacement With the Melody Valve

Presenter: John P. Cheatham

May 13, 2015

Presentation

Postoperative Delirium Increases Mortality After Surgical or Transcatheter Aortic Valve Replacement

Presenter: Hersh S. Maniar

May 01, 2015

Presentation ACC 2015

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

Presenter: Michael J. Mack

March 15, 2015

Presentation ACC 2015

A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes

Presenter: Michael J. Reardon

March 15, 2015

Presentation

Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement

Presenter: David Holmes Jr.

March 10, 2015

Presentation Cardiovascular Interventions 2014

Transcatheter Aortic Valve Replacement: State of the Art

Presenter: Paul S. Teirstein

October 23, 2014

Presentation Cardiovascular Interventions 2014

Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Paul S. Teirstein

October 23, 2014

Presentation TCT 2014

TCT 700: Multicenter Evaluation of Transcatheter Aortic Valve Replacement Using Either SAPIEN XT or CoreValve: Degree of Device Oversizing and Clinical Outcomes

Presenter: Danny Dvir

September 16, 2014

Presentation TCT 2014

TCT 701: A Multidisciplinary, Multimodality but Minimalist (3M) Approach to Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next-Day Discharge Home in High-Risk Patients: 1-Year Follow-up

Presenter: Danny Dvir

September 16, 2014

Presentation TCT 2014

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

Presenter: James B. Hermiller Jr, Susheel Kodali, Augusto D. Pichard, Alan Zajarias

September 16, 2014

Presentation TCT 2014

TCT 697: Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights from the PARTNER Trial

Presenter: Philippe Pibarot, Allan Schwartz, Gary Gershony, Josep Rodés-Cabau

September 16, 2014

Presentation TCT 2014

TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial

Presenter: Thomas F. Luscher, Danny Dvir

September 16, 2014

Presentation TCT 2014

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

Presenter: William Wilson

September 16, 2014

Presentation TCT 2014

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Presenter: Christopher Meduri

September 16, 2014

Presentation TCT 2014

Comparison of 30-day Major Vascular Complications between Transfemoral and Transapical Accesses in Transcatheter Aortic Valve Replacement: an Updated Meta-Analysis using___

Presenter: Rhanderson Cardoso

September 16, 2014

Presentation TCT 2014

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Presenter: Luis Nombela-Franco

September 16, 2014

Presentation TCT 2014

The Role of Right Sided Hemodynamic Parameters as Predictors of 30 Day Outcome After Transcatheter Aortic Valve Replacement: The Impact of Right Ventricular Stroke Work Index

Presenter: Rajiv Tayal

September 16, 2014

Presentation TCT 2014

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

Presenter: Ronald Binder

September 16, 2014

Presentation TCT 2014

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Presenter: Ian T. Meredith

September 15, 2014

Presentation TCT 2014

TCT 690: Safety and Efficacy of Urgent Transcatheter Aortic Valve Replacement in Patients Admitted with Decompensated Heart Failure

Presenter: Howard C. Herrmann, Spencer H. Kubo, Sami Alnasser

September 15, 2014

Advertisement

Outcomes Up to 7 Years After Transcatheter Pulmonary Valve Replacement With the Melody Valve

Postoperative Delirium Increases Mortality After Surgical or Transcatheter Aortic Valve Replacement

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes

Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement: State of the Art

Transcatheter Aortic Valve Replacement (TAVR)

TCT 700: Multicenter Evaluation of Transcatheter Aortic Valve Replacement Using Either SAPIEN XT or CoreValve: Degree of Device Oversizing and Clinical Outcomes

TCT 701: A Multidisciplinary, Multimodality but Minimalist (3M) Approach to Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next-Day Discharge Home in High-Risk Patients: 1-Year Follow-up

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

TCT 697: Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights from the PARTNER Trial

TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Comparison of 30-day Major Vascular Complications between Transfemoral and Transapical Accesses in Transcatheter Aortic Valve Replacement: an Updated Meta-Analysis using___

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

The Role of Right Sided Hemodynamic Parameters as Predictors of 30 Day Outcome After Transcatheter Aortic Valve Replacement: The Impact of Right Ventricular Stroke Work Index

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

TCT 690: Safety and Efficacy of Urgent Transcatheter Aortic Valve Replacement in Patients Admitted with Decompensated Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content